Allergy and Immunology · San Francisco, CA
NPI
1629156229
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2200 Ofarrell St
San Francisco, CA, 94115
Phone (415) 833-2000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$253K
760 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Calvin S So prescribed most often to Medicare patients was Azelastine Hcl, with 126 prescriptions and refills. In total Calvin S So wrote 760 Medicare prescriptions that cost $253K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Azelastine Hcl Generic | 126 | 157 | 52 | $2,521 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 86 | 86 | 43 | $1,436 |
| Spiriva Respimat Tiotropium Bromide | 80 | 160 | 22 | $37K |
| Fluticasone Propionate Generic | 67 | 71 | 22 | $1,285 |
| Breyna Budesonide/Formoterol Fumarate | 60 | 116 | 22 | $14K |
| Montelukast Sodium Generic | 54 | 123 | 25 | $515 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 48 | 96 | 22 | $10K |
| Asmanex Hfa Mometasone Furoate | 31 | 35 | 11 | $4,202 |
| Alvesco Ciclesonide | 29 | 40 | Under 11 | $3,893 |
| Ipratropium Bromide Generic | 24 | 30 | 12 | $509 |
| Prednisone Generic | 23 | 23 | 19 | $160 |
| Advair Hfa Fluticasone Propion/Salmeterol | 18 | 36 | Under 11 | $13K |
| Epinephrine Generic | 18 | 18 | 13 | $2,186 |
| Hydroxyzine Hcl Generic | 13 | 15 | Under 11 | $98.7 |
Brand drugs: 317 claims; generic drugs: 443 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Calvin S So were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.